<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">26462910</PMID><DateCompleted><Year>2016</Year><Month>06</Month><Day>20</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1423-0127</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><PubDate><Year>2015</Year><Month>Oct</Month><Day>14</Day></PubDate></JournalIssue><Title>Journal of biomedical science</Title><ISOAbbreviation>J Biomed Sci</ISOAbbreviation></Journal><ArticleTitle>Biomarkers of severe dengue disease - a review.</ArticleTitle><Pagination><StartPage>83</StartPage><MedlinePgn>83</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">83</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12929-015-0191-6</ELocationID><Abstract><AbstractText>Dengue virus infection presents a wide spectrum of manifestations including asymptomatic condition, dengue fever (DF), or severe forms, such as dengue hemorrhagic fever (DHF) and dengue shock syndrome (DSS) in affected individuals. The early prediction of severe dengue in patients without any warning signs who may later develop severe DHF is very important to choose appropriate intensive supportive therapy since available vaccines for immunization are yet to be approved. Severe dengue responses include T and B cell activation and apoptosis, cytokine storm, hematologic disorders and complement activation. Cytokines, complement and other unidentified factors may transiently act on the endothelium and alter normal fluid barrier function of the endothelial cells and cause plasma leakage. In this review, the host factors such as activated immune and endothelial cells and their products which can be utilized as biomarkers for severe dengue disease are discussed.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>John</LastName><ForeName>Daisy Vanitha</ForeName><Initials>DV</Initials><AffiliationInfo><Affiliation>Biotechnology Research Institute, University Malaysia Sabah, Kota Kinabalu, Sabah, Malaysia. daisyv@ums.edu.my.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Yee-Shin</ForeName><Initials>YS</Initials><AffiliationInfo><Affiliation>Center of Infectious Disease and Signaling Research, Department of Microbiology and Immunology, College of Medicine, National Cheng Kung University, Tainan, Taiwan. yslin1@mail.ncku.edu.tw.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Perng</LastName><ForeName>Guey Chuen</ForeName><Initials>GC</Initials><AffiliationInfo><Affiliation>Center of Infectious Disease and Signaling Research, Department of Microbiology and Immunology, College of Medicine, National Cheng Kung University, Tainan, Taiwan. gperng@mail.ncku.edu.tw.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>10</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Biomed Sci</MedlineTA><NlmUniqueID>9421567</NlmUniqueID><ISSNLinking>1021-7770</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016207">Cytokines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001402" MajorTopicYN="N">B-Lymphocytes</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016207" MajorTopicYN="N">Cytokines</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003715" MajorTopicYN="N">Dengue</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004730" MajorTopicYN="N">Endothelium, Vascular</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="Y">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013601" MajorTopicYN="N">T-Lymphocytes</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>3</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>9</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>10</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>10</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>6</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26462910</ArticleId><ArticleId IdType="pmc">PMC4604634</ArticleId><ArticleId IdType="doi">10.1186/s12929-015-0191-6</ArticleId><ArticleId IdType="pii">10.1186/s12929-015-0191-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>World Health Organization (WHO) and the Special Programme for Research and Training in Tropical Diseases (TDR) Dengue guidelines for diagnosis, treatment, prevention and control. 2009.</Citation></Reference><Reference><Citation>Zhang H, Zhou YP, Peng HJ, Zhang XH, Zhou FY, Liu ZH, et al. Predictive symptoms and signs of severe dengue disease for patients with dengue fever: a meta-analysis. Biomed Res Int. 2014;2014:359308.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4100454</ArticleId><ArticleId IdType="pubmed">25097856</ArticleId></ArticleIdList></Reference><Reference><Citation>Pang T, Cardosa MJ, Guzman MG. Of cascades and perfect storms: the immunopathogenesis of dengue haemorrhagic fever-dengue shock syndrome (DHF/DSS) Immunol Cell Biol. 2007;85:43&#x2013;5. doi: 10.1038/sj.icb.7100008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.icb.7100008</ArticleId><ArticleId IdType="pubmed">17130899</ArticleId></ArticleIdList></Reference><Reference><Citation>Nielsen DG. The relationship of interacting immunological components in dengue pathogenesis. Virol J. 2009;6:211. doi: 10.1186/1743-422X-6-211.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-422X-6-211</ArticleId><ArticleId IdType="pmc">PMC2789730</ArticleId><ArticleId IdType="pubmed">19941667</ArticleId></ArticleIdList></Reference><Reference><Citation>Perng GC, Chokephaibulkit K. Immunologic hypo- or non-responder in natural dengue virus infection. J Biomed Sci. 2013;20:34. doi: 10.1186/1423-0127-20-34.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1423-0127-20-34</ArticleId><ArticleId IdType="pmc">PMC3680176</ArticleId><ArticleId IdType="pubmed">23725050</ArticleId></ArticleIdList></Reference><Reference><Citation>Green S, Rothman A. Immunopathological mechanisms in dengue and dengue hemorrhagic fever. Curr Opin Infect Dis. 2006;19:429&#x2013;36. doi: 10.1097/01.qco.0000244047.31135.fa.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.qco.0000244047.31135.fa</ArticleId><ArticleId IdType="pubmed">16940865</ArticleId></ArticleIdList></Reference><Reference><Citation>Pawitan JA. Dengue virus infection: predictors for severe dengue. Acta Med Indones. 2011;43:129&#x2013;35.</Citation><ArticleIdList><ArticleId IdType="pubmed">21785176</ArticleId></ArticleIdList></Reference><Reference><Citation>Dalrymple NA, Mackow ER. Roles for endothelial cells in dengue virus infection. Adv Virol. 2012;2012.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3431041</ArticleId><ArticleId IdType="pubmed">22952474</ArticleId></ArticleIdList></Reference><Reference><Citation>Srikiatkhachorn A, Green S. Markers of dengue disease severity. Curr Top Microbiol Immunol. 2010;338:67&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pubmed">19802579</ArticleId></ArticleIdList></Reference><Reference><Citation>Page AV, Liles WC. Biomarkers of endothelial activation/dysfunction in infectious diseases. Virulence. 2013;4:507&#x2013;16. doi: 10.4161/viru.24530.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/viru.24530</ArticleId><ArticleId IdType="pmc">PMC5359744</ArticleId><ArticleId IdType="pubmed">23669075</ArticleId></ArticleIdList></Reference><Reference><Citation>Fink J, Gu F, Vasudevan SG. Role of T cells, cytokines and antibody in dengue fever and dengue haemorrhagic fever. Rev Med Virol. 2006;16:263&#x2013;75. doi: 10.1002/rmv.507.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.507</ArticleId><ArticleId IdType="pubmed">16791836</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho JJ, Wang JJ, Shaio MF, Kao CL, Chang DM, Han SW, et al. Infection of human dendritic cells by dengue virus causes cell maturation and cytokine production. J Immunol. 2001;166:1499&#x2013;506. doi: 10.4049/jimmunol.166.3.1499.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.166.3.1499</ArticleId><ArticleId IdType="pubmed">11160189</ArticleId></ArticleIdList></Reference><Reference><Citation>Prestwood TR, May MM, Plummer EM, Morar MM, Yauch LE, Shresta S. Trafficking and replication patterns reveal splenic macrophages as major targets of dengue virus in mice. J Virol. 2012;86:12138&#x2013;47. doi: 10.1128/JVI.00375-12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00375-12</ArticleId><ArticleId IdType="pmc">PMC3486461</ArticleId><ArticleId IdType="pubmed">22933295</ArticleId></ArticleIdList></Reference><Reference><Citation>Pichyangkul S, Endy TP, Kalayanarooj S, Nisalak A, Yongvanitchit K, Green S, et al. A blunted blood plasmacytoid dendritic cell response to an acute systemic viral infection is associated with increased disease severity. J Immunol. 2003;171:5571&#x2013;8. doi: 10.4049/jimmunol.171.10.5571.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.171.10.5571</ArticleId><ArticleId IdType="pubmed">14607965</ArticleId></ArticleIdList></Reference><Reference><Citation>De Carvalho BM, Martial J, Cabi&#xe9; A, Thomas L, C&#xe9;saire R. Decreased peripheral dendritic cell numbers in dengue virus infection. J Clin Immunol. 2012;32:161&#x2013;72. doi: 10.1007/s10875-011-9592-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10875-011-9592-9</ArticleId><ArticleId IdType="pubmed">21969208</ArticleId></ArticleIdList></Reference><Reference><Citation>Libraty DH, Pichyangkul S, Ajariyakhajorn C, Endy TP, Ennis FA. Human dendritic cells are activated by dengue virus infection: Enhancement by gamma interferon and implications for disease pathogenesis. J Virol April. 2001;75:3501&#x2013;08. doi: 10.1128/JVI.75.8.3501-3508.2001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.75.8.3501-3508.2001</ArticleId><ArticleId IdType="pmc">PMC114841</ArticleId><ArticleId IdType="pubmed">11264339</ArticleId></ArticleIdList></Reference><Reference><Citation>Luplerdlop N, Misse D, Bray D, Deleuze V, Gonzalez JP, Leardkamolkarn V, et al. Dengue virus infected dendritic cells trigger vascular leakage through metalloproteinase over production. EMBO Rep. 2006;7:1176&#x2013;81. doi: 10.1038/sj.embor.7400814.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.embor.7400814</ArticleId><ArticleId IdType="pmc">PMC1679776</ArticleId><ArticleId IdType="pubmed">17028575</ArticleId></ArticleIdList></Reference><Reference><Citation>Green S, Pichyangkul S, Vaughn DW, Kalayanarooj S, Nimmannitya S, Nisalak A, et al. Early CD69 expression on peripheral blood lymphocytes from children with dengue hemorrhagic fever. J Infect Dis. 1999;180:1429&#x2013;35. doi: 10.1086/315072.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/315072</ArticleId><ArticleId IdType="pubmed">10515800</ArticleId></ArticleIdList></Reference><Reference><Citation>Azeredo EL, De Oliveira-Pinto LM, Zagne SM, Cerqueira DI, Nogueira RM, Kubelka CF. NK cells, displaying early activation, cytotoxicity and adhesion molecules, are associated with mild dengue disease. Clin Exp Immunol. 2006;143:345&#x2013;56. doi: 10.1111/j.1365-2249.2006.02996.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2249.2006.02996.x</ArticleId><ArticleId IdType="pmc">PMC1809585</ArticleId><ArticleId IdType="pubmed">16412060</ArticleId></ArticleIdList></Reference><Reference><Citation>Azeredo EL, Zagne SM, Alvarenga AR, Nogueira RM, Kubelka CF, de Oliveira-Pinto LM. Activated peripheral lymphocytes with increased expression of cell adhesion molecules and cytotoxic markers are associated with dengue fever disease. Mem Inst Oswaldo Cruz. 2006;101:437&#x2013;49.</Citation><ArticleIdList><ArticleId IdType="pubmed">16951817</ArticleId></ArticleIdList></Reference><Reference><Citation>Myint KS, Endy TP, Mongkolsirichaikul D, Manomuth C, Kalayanarooj S, Vaughn DW, et al. Cellular immune activation in children with acute dengue virus infections is modulated by apoptosis. J Infect Dis. 2006;194:600&#x2013;7. doi: 10.1086/506451.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/506451</ArticleId><ArticleId IdType="pubmed">16897658</ArticleId></ArticleIdList></Reference><Reference><Citation>Torrentes-Carvalho A, Marinho CF, de Oliveira-Pinto LM, de Oliveira DB, Damasco PV, Cunha RV, et al. Regulation of T lymphocyte apoptotic markers is associated to cell activation during the acute phase of dengue. Immunobiology. 2014;219:329&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pubmed">24508270</ArticleId></ArticleIdList></Reference><Reference><Citation>Mongkolsapaya J, Duangchinda T, Dejnirattisai W, Vasanawathana S, Avirutnan P, Jairungsri A, et al. T cell responses in dengue hemorrhagic fever: are cross-reactive T cells suboptimal? J Immunol. 2006;176:3821&#x2013;29. doi: 10.4049/jimmunol.176.6.3821.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.176.6.3821</ArticleId><ArticleId IdType="pubmed">16517753</ArticleId></ArticleIdList></Reference><Reference><Citation>Beaumier CM, Mathew A, Bashyam HS, Rothman AL. Cross-reactive memory CD8(+) T cells alter the immune response to heterologous secondary dengue virus infections in mice in a sequence-specific manner. J Infect Dis. 2008;197:608&#x2013;17. doi: 10.1086/526790.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/526790</ArticleId><ArticleId IdType="pubmed">18275279</ArticleId></ArticleIdList></Reference><Reference><Citation>Witczak P, Brzezi&#x144;ska-B&#x142;aszczyk E. Mast cells in viral infections. Postepy Hig Med Dosw. 2012;66:231&#x2013;41. doi: 10.5604/17322693.991610.</Citation><ArticleIdList><ArticleId IdType="doi">10.5604/17322693.991610</ArticleId><ArticleId IdType="pubmed">22706109</ArticleId></ArticleIdList></Reference><Reference><Citation>King CA, Anderson R, Marshall JS. Dengue virus selectively induces human mast cell chemokine production. J Virol. 2002;76:8408&#x2013;19. doi: 10.1128/JVI.76.16.8408-8419.2002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.76.16.8408-8419.2002</ArticleId><ArticleId IdType="pmc">PMC155122</ArticleId><ArticleId IdType="pubmed">12134044</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown MG, McAlpine SM, Huang YY, Haidl ID, Al-Afif A, Marshall JS, et al. RNA sensors enable human mast cell anti-viral chemokine production and IFN-mediated protection in response to antibody-enhanced dengue virus infection. PLoS One. 2012;7:e34055. doi: 10.1371/journal.pone.0034055.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0034055</ArticleId><ArticleId IdType="pmc">PMC3316603</ArticleId><ArticleId IdType="pubmed">22479521</ArticleId></ArticleIdList></Reference><Reference><Citation>Furuta T, Murao LA, Lan NT, Huy NT, Huong VT, Thuy TT, et al. Association of mast cell-derived VEGF and proteases in Dengue shock syndrome. PLoS Negl Trop Dis. 2012;6:e1505. doi: 10.1371/journal.pntd.0001505.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0001505</ArticleId><ArticleId IdType="pmc">PMC3283553</ArticleId><ArticleId IdType="pubmed">22363824</ArticleId></ArticleIdList></Reference><Reference><Citation>Clark KB, Noisakran S, Onlamoon N, Hsiao HM, Roback J, Villinger F, et al. Multiploid CD61+ cells are the pre-dominant cell lineage infected during acute dengue virus infection in bone marrow. PLoS One. 2012;7:e52902. doi: 10.1371/journal.pone.0052902.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0052902</ArticleId><ArticleId IdType="pmc">PMC3531377</ArticleId><ArticleId IdType="pubmed">23300812</ArticleId></ArticleIdList></Reference><Reference><Citation>Sridharan A, Chen Q, Tang KF, Ooi EE, Hibberd ML, Chen J. Inhibition of megakaryocyte development in the bone marrow underlies dengue virus-induced thrombocytopenia in humanized mice. J Virol. 2013;87:11648&#x2013;58. doi: 10.1128/JVI.01156-13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01156-13</ArticleId><ArticleId IdType="pmc">PMC3807371</ArticleId><ArticleId IdType="pubmed">23966397</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun DS, King CC, Huang HS, Shih YL, Lee CC, Tsai WJ, et al. Antiplatelet autoantibodies elicited by dengue virus non-structural protein 1 cause thrombocytopenia and mortality in mice. J Thromb Haemost. 2007;5:2291&#x2013;99. doi: 10.1111/j.1538-7836.2007.02754.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1538-7836.2007.02754.x</ArticleId><ArticleId IdType="pubmed">17958746</ArticleId></ArticleIdList></Reference><Reference><Citation>Malavige GN, Gomes L, Alles L, Chang T, Salimi M, Fernando S, et al. Serum IL-10 as a marker of severe dengue infection. BMC Infect Dis. 2013;13:341. doi: 10.1186/1471-2334-13-341.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2334-13-341</ArticleId><ArticleId IdType="pmc">PMC3733887</ArticleId><ArticleId IdType="pubmed">23883139</ArticleId></ArticleIdList></Reference><Reference><Citation>Trairatvorakul P, Chongsrisawat V, Ngamvasinont D, Asawarachun D, Nantasook J, Poovorawan Y. Serum nitric oxide in children with dengue infection. Asian Pac J Allergy. 2005;23:115&#x2013;19.</Citation><ArticleIdList><ArticleId IdType="pubmed">16252841</ArticleId></ArticleIdList></Reference><Reference><Citation>Juffrie M, van Der Meer GM, Hack CE, Haasnoot K, Sutaryo, Veerman AJ, et al. Inflammatory mediators in dengue virus infection in children: interleukin-8 and its relationship to neutrophil degranulation. Infect Immun. 2000;68:702&#x2013;07.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC97195</ArticleId><ArticleId IdType="pubmed">10639436</ArticleId></ArticleIdList></Reference><Reference><Citation>Green S, Vaughn DW, Kalayanarooj S, Nimmannitya S, Suntayakorn S, Nisalak A, et al. Elevated plasma interleukin-10 levels in acute dengue correlate with disease severity. J Med Virol. 1999;59:329&#x2013;34. doi: 10.1002/(SICI)1096-9071(199911)59:3&lt;329::AID-JMV12&gt;3.0.CO;2-G.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/(SICI)1096-9071(199911)59:3&lt;329::AID-JMV12&gt;3.0.CO;2-G</ArticleId><ArticleId IdType="pubmed">10502265</ArticleId></ArticleIdList></Reference><Reference><Citation>Mustafa AS, Elbishbishi EA, Agarwal R, Chaturvedi UC. Elevated levels of interleukin-13 and IL-18 in patients with dengue hemorrhagic fever. FEMS Immunol Med Microbiol. 2001;30:229&#x2013;33. doi: 10.1111/j.1574-695X.2001.tb01575.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1574-695X.2001.tb01575.x</ArticleId><ArticleId IdType="pubmed">11335143</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinto LM, Oliveira SA, Braga EL, Nogueira RM, Kubelka CF. Increased proinflammatory cytokines (TNF-alpha and IL-6) and anti-inflammatory compounds (sTNFRp55 and sTNFRp75) in Brazilian patients during exanthematic dengue fever. Mem Inst Oswaldo Cruz. 1999;94:387&#x2013;94. doi: 10.1590/S0074-02761999000300019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/S0074-02761999000300019</ArticleId><ArticleId IdType="pubmed">10348988</ArticleId></ArticleIdList></Reference><Reference><Citation>van de Weg CA, Pannuti CS, de Ara&#xfa;jo ES, van den Ham HJ, Andeweg AC, Boas LS, et al. Microbial translocation is associated with extensive immune activation in dengue virus infected patients with severe disease. PLoS Negl Trop Dis. 2013;7:e2236.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3662706</ArticleId><ArticleId IdType="pubmed">23717702</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen LC, Lei HY, Liu CC, Shiesh SC, Chen SH, Liu HS, et al. Correlation of serum levels of macrophage migration inhibitory factor with disease severity and clinical outcome in dengue patients. Am J Trop Med Hyg. 2006;74:142&#x2013;47.</Citation><ArticleIdList><ArticleId IdType="pubmed">16407359</ArticleId></ArticleIdList></Reference><Reference><Citation>Bozza FA, Cruz OG, Zagne SM, Azeredo EL, Nogueira RM, Assis EF, et al. Multiplex cytokine profile from dengue patients: MIP-1beta and IFN-gamma as predictive factors for severity. BMC Infect Dis. 2008;8:86. doi: 10.1186/1471-2334-8-86.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2334-8-86</ArticleId><ArticleId IdType="pmc">PMC2474613</ArticleId><ArticleId IdType="pubmed">18578883</ArticleId></ArticleIdList></Reference><Reference><Citation>Rachman A, Rinaldi I. Coagulopathy in dengue infection and the role of interleukin-6. Acta Med Indones. 2006;38:105&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">16799214</ArticleId></ArticleIdList></Reference><Reference><Citation>Avila-Aguero ML, Avila-Aguero CR, Um SL, Soriano-Fallas A, Ca&#xf1;as-Coto A, Yan SB. Systemic host inflammatory and coagulation response in the Dengue virus primo-infection. Cytokine. 2004;27:173&#x2013;9. doi: 10.1016/j.cyto.2004.05.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cyto.2004.05.007</ArticleId><ArticleId IdType="pubmed">15304247</ArticleId></ArticleIdList></Reference><Reference><Citation>Bethell DB, Flobbe K, Cao XT, Day NP, Pham TP, Buurman WA, et al. Pathophysiologic and prognostic role of cytokines in dengue hemorrhagic fever. J Infect Dis. 1998;177:778&#x2013;82. doi: 10.1086/517807.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/517807</ArticleId><ArticleId IdType="pubmed">9498463</ArticleId></ArticleIdList></Reference><Reference><Citation>Houghton-Trivi&#xf1;o N, Salgado DM, Rodr&#xed;guez JA, Bosch I, Castellanos JE. Levels of soluble ST2 in serum associated with severity of dengue due to tumour necrosis factor alpha stimulation. Gen Virol. 2010;91:697&#x2013;706. doi: 10.1099/vir.0.012971-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.012971-0</ArticleId><ArticleId IdType="pubmed">19889931</ArticleId></ArticleIdList></Reference><Reference><Citation>Assun&#xe7;&#xe3;o-Miranda I, Amaral FA, Bozza FA, Fagundes CT, Sousa LP, Souza DG, et al. Contribution of macrophage migration inhibitory factor to the pathogenesis of dengue virus infection. FASEB J. 2010;24:218&#x2013;28. doi: 10.1096/fj.09-139469.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.09-139469</ArticleId><ArticleId IdType="pubmed">19776337</ArticleId></ArticleIdList></Reference><Reference><Citation>De-Oliveira-Pinto LM, Gandini M, Freitas LP, Siqueira MM, Marinho CF, Set&#xfa;bal S, et al. Profile of circulating levels of IL-1Ra, CXCL10/IP-10, CCL4/MIP-1&#x3b2; and CCL2/MCP-1 in dengue fever and parvovirosis. Mem Inst Oswaldo Cruz. 2012;107:48&#x2013;56. doi: 10.1590/S0074-02762012000100007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/S0074-02762012000100007</ArticleId><ArticleId IdType="pubmed">22310535</ArticleId></ArticleIdList></Reference><Reference><Citation>Nascimento EJ, Silva AM, Cordeiro MT, Brito CA, Gil LH, Braga-Neto U, et al. Alternative complement pathway deregulation is correlated with dengue severity. PLoS One. 2009;4:e6782. doi: 10.1371/journal.pone.0006782.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0006782</ArticleId><ArticleId IdType="pmc">PMC2728508</ArticleId><ArticleId IdType="pubmed">19707565</ArticleId></ArticleIdList></Reference><Reference><Citation>Avirutnan P, Punyadee N, Noisakran S, Komoltri C, Thiemmeca S, Auethavornanan K, et al. Vascular leakage in severe dengue virus infections: a potential role for the nonstructural viral protein NS1 and complement. J Infect Dis. 2006;193:1078&#x2013;88. doi: 10.1086/500949.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/500949</ArticleId><ArticleId IdType="pubmed">16544248</ArticleId></ArticleIdList></Reference><Reference><Citation>Kolitha HS. Pathogenesis of Dengue Haemorrhagic Fever and Its Impact on Case Management. ISRN Infectious Diseases. 2013;2013:1-6. doi:10.5402/2013/571646</Citation></Reference><Reference><Citation>Koraka P, Murgue B, Deparis X, Setiati TE, Suharti C, van Gorp EC, et al. Elevated levels of total and dengue virus specific immunoglobulin E in patients with disease of varying severity. J Med Virol. 2003;70:91&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">12629649</ArticleId></ArticleIdList></Reference><Reference><Citation>Saito M, Oishi K, Inoue S, Dimaano EM, Alera MT, Robles AM, et al. Association of increased platelet associated immunoglobulins with thrombocytopenia and the severity of disease in secondary dengue virus infections. Clin Exp Immunol. 2004;138:299&#x2013;303. doi: 10.1111/j.1365-2249.2004.02626.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2249.2004.02626.x</ArticleId><ArticleId IdType="pmc">PMC1809201</ArticleId><ArticleId IdType="pubmed">15498040</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin CF, Lei HY, Shiau AL, Liu HS, Yeh TM, Chen SH, et al. Endothelial cell apoptosis induced by antibodies against dengue virus nonstructural protein 1 via production of nitric oxide. J Immunol. 2002;169:657&#x2013;64. doi: 10.4049/jimmunol.169.2.657.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.169.2.657</ArticleId><ArticleId IdType="pubmed">12097367</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurane I, Innis BL, Nimmannitya S, Nisalak A, Meager A, Janus J, et al. Activation of T lymphocytes in dengue virus infections. High levels of soluble interleukin 2 receptor, soluble CD4, soluble CD8, interleukin 2, and interferon-g in sera of children with dengue. J Clin Invest. 1991;88:1473&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC295652</ArticleId><ArticleId IdType="pubmed">1939640</ArticleId></ArticleIdList></Reference><Reference><Citation>Becerra A, Warke RV, de Bosch N, Rothman AL, Bosch I. Elevated levels of soluble ST2 protein in dengue virus infected patients. Cytokine. 2008;41:114&#x2013;20. doi: 10.1016/j.cyto.2007.11.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cyto.2007.11.001</ArticleId><ArticleId IdType="pmc">PMC2276732</ArticleId><ArticleId IdType="pubmed">18226917</ArticleId></ArticleIdList></Reference><Reference><Citation>Jessie K, Fong MY, Devi S, Lam SK, Wong KT. Localization of dengue virus in naturally infected human tissues, by immunohistochemistry and in situ hybridization. J Infect Dis. 2004;189:1411&#x2013;8. doi: 10.1086/383043.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/383043</ArticleId><ArticleId IdType="pubmed">15073678</ArticleId></ArticleIdList></Reference><Reference><Citation>Bosch I, Xhaja K, Estevez L, Raines G, Melichar H, Warke RV, et al. Increased production of interleukin-8 in primary human monocytes and in human epithelial and endothelial cell lines after dengue virus challenge. J Virol. 2002;76:5588&#x2013;97. doi: 10.1128/JVI.76.11.5588-5597.2002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.76.11.5588-5597.2002</ArticleId><ArticleId IdType="pmc">PMC137016</ArticleId><ArticleId IdType="pubmed">11991987</ArticleId></ArticleIdList></Reference><Reference><Citation>Avirutnan P, Malasit P, Seliger B, Bhakdi S, Husmann M. Dengue virus infection of human endothelial cells leads to chemokine production, complement activation, and apoptosis. J Immunol. 1998;161:6338&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="pubmed">9834124</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang YH, Lei HY, Liu HS, Lin YS, Liu CC, Yeh TM. Dengue virus infects human endothelial cells and induces IL-6 and IL-8 production. Am J Trop Med Hyg. 2000;63:71&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">11357999</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee WL, Liles WC. Endothelial activation, dysfunction and permeability during severe infections. Curr Opin Hematol. 2011;18:191&#x2013;6. doi: 10.1097/MOH.0b013e328345a3d1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MOH.0b013e328345a3d1</ArticleId><ArticleId IdType="pubmed">21423012</ArticleId></ArticleIdList></Reference><Reference><Citation>Michels M, van der Ven AJ, Djamiatun K, Fijnheer R, de Groot PG, Griffioen AW, et al. Imbalance of angiopoietin-1 and angiopoetin-2 in severe dengue and relationship with thrombocytopenia, endothelial activation, and vascular stability. Am J Trop Med Hyg. 2012;87:943&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3516273</ArticleId><ArticleId IdType="pubmed">22949515</ArticleId></ArticleIdList></Reference><Reference><Citation>Lowenstein CJ, Morrell CN, Yamakuchi M. Regulation of Weibel-Palade body exocytosis. Trends Cardiovasc Med. 2005;15:302&#x2013;8. doi: 10.1016/j.tcm.2005.09.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tcm.2005.09.005</ArticleId><ArticleId IdType="pubmed">16297768</ArticleId></ArticleIdList></Reference><Reference><Citation>Tati R, Kristoffersson AC, St&#xe5;hl AL, M&#xf6;rgelin M, Motto D, Satchell S, et al. Phenotypic expression of ADAMTS13 in glomerular endothelial cells. PLoS One. 2011;6:e21587. doi: 10.1371/journal.pone.0021587.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0021587</ArticleId><ArticleId IdType="pmc">PMC3123364</ArticleId><ArticleId IdType="pubmed">21720563</ArticleId></ArticleIdList></Reference><Reference><Citation>Djamiatun K, van der Ven AJAM, de Groot PG, Faradz SM, Hapsari D, Dolmans WM, et al. Severe dengue is associated with consumption of von Willebrand factor and its cleaving enzyme ADAMTS-13. PLoS Negl Trop Dis. 2012;6:e1628.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3341341</ArticleId><ArticleId IdType="pubmed">22563509</ArticleId></ArticleIdList></Reference><Reference><Citation>Butthep P, Chunhakan S, Tangnararatchakit K, Yoksan S, Pattanapanyasat K, Chuansumrit A. Elevated soluble thrombomodulin in the febrile stage related to patients at risk for dengue shock syndrome. Pediatr Infect Dis J. 2006;25:894&#x2013;7. doi: 10.1097/01.inf.0000237918.85330.b9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.inf.0000237918.85330.b9</ArticleId><ArticleId IdType="pubmed">17006283</ArticleId></ArticleIdList></Reference><Reference><Citation>Wills BA, Oragui EE, Stephens AC, Daramola OA, Dung NM, Loan HT, et al. Coagulation abnormalities in dengue hemorrhagic Fever: serial investigations in 167 Vietnamese children with Dengue shock syndrome. Clin Infect Dis. 2002;35:277&#x2013;85. doi: 10.1086/341410.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/341410</ArticleId><ArticleId IdType="pubmed">12115093</ArticleId></ArticleIdList></Reference><Reference><Citation>Koraka P, Murgue B, Deparis X, Van Gorp EC, Setiati TE, Osterhaus AD, et al. Elevation of soluble VCAM-1 plasma levels in children with acute dengue virus infection of varying severity. J Med Virol. 2004;72:445&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pubmed">14748068</ArticleId></ArticleIdList></Reference><Reference><Citation>Khongphatthanayothin A, Phumaphuti P, Thongchaiprasit K, Poovorawan Y. Serum levels of sICAM-1 and sE-selectin in patients with dengue virus infection. Jpn J Infect Dis. 2006;59:186&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">16785701</ArticleId></ArticleIdList></Reference><Reference><Citation>Shibuya M, Ito N, Claesson-Welsh L. Structure and function of vascular endothelial growth factor receptor-1 and &#x2212;2. Curr Top Microbiol Immunol. 1999;237:59&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pubmed">9893346</ArticleId></ArticleIdList></Reference><Reference><Citation>van de Weg CA, Pannuti CS, van den Ham HJ, de Ara&#xfa;jo ES, Boas LS, Felix AC, et al. Serum angiopoietin-2 and soluble VEGF receptor 2 are surrogate markers for plasma leakage in patients with acute dengue virus infection. J Clin Virol. 2014;60:328&#x2013;35.</Citation><ArticleIdList><ArticleId IdType="pubmed">24928471</ArticleId></ArticleIdList></Reference><Reference><Citation>van Gorp EC, Suharti C, Mairuhu AT, Dolmans WM, van Der Ven J, Demacker PN, et al. Changes in the plasma lipid profile as a potential predictor of clinical outcome in dengue hemorrhagic fever. Clin Infect Dis. 2002;34:1150&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pubmed">11915007</ArticleId></ArticleIdList></Reference><Reference><Citation>de Souza LJ, Nogueira RM, Soares LC, Soares CE, Ribas BF, Alves FP, et al. The impact of dengue on liver function as evaluated by aminotransferase levels. Braz J Infect Dis. 2007;11:407&#x2013;10. doi: 10.1590/S1413-86702007000400007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/S1413-86702007000400007</ArticleId><ArticleId IdType="pubmed">17873994</ArticleId></ArticleIdList></Reference><Reference><Citation>Laoprasopwattana K, Tangcheewawatthanakul C, Tunyapanit W, Sangthong R. Is zinc concentration in toxic phase plasma related to dengue severity and level of transaminases? PLoS Negl Trop Dis. 2013;7:e2287. doi: 10.1371/journal.pntd.0002287.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0002287</ArticleId><ArticleId IdType="pmc">PMC3688526</ArticleId><ArticleId IdType="pubmed">23819001</ArticleId></ArticleIdList></Reference><Reference><Citation>Koraka P, Lim YP, Shin MD, Setiati TE, Mairuhu AT, van Gorp EC, et al. Plasma levels of inter-alpha inhibitor proteins in children with acute Dengue virus infection. PLoS One. 2010;5:e9967.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2850310</ArticleId><ArticleId IdType="pubmed">20386596</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaturvedi UC, Nagar R. Nitric oxide in dengue and dengue haemorrhagic fever: necessity or nuisance? FEMS Immunol Med Microbiol. 2009;56:9&#x2013;24. doi: 10.1111/j.1574-695X.2009.00544.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1574-695X.2009.00544.x</ArticleId><ArticleId IdType="pmc">PMC7110348</ArticleId><ArticleId IdType="pubmed">19239490</ArticleId></ArticleIdList></Reference><Reference><Citation>Valero N, Espina LM, A&#x2dc;nez G, Torres E, Mosquera JA. Short report: increased level of serum nitric oxide in patients with dengue. Am J Trop Med Hyg. 2002;66:762&#x2013;764.</Citation><ArticleIdList><ArticleId IdType="pubmed">12224588</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramilo O, Allman W, Chung W, Mejias A, Ardura M, Glaser C, et al. Gene expression patterns in blood leukocytes discriminate patients with acute infections. Blood. 2007;109:2066&#x2013;2077. doi: 10.1182/blood-2006-02-002477.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2006-02-002477</ArticleId><ArticleId IdType="pmc">PMC1801073</ArticleId><ArticleId IdType="pubmed">17105821</ArticleId></ArticleIdList></Reference><Reference><Citation>Nascimento EJ, Braga-Neto U, Calzavara-Silva CE, Gomes AL, Abath FG, Brito CA, et al. Gene expression profiling during early acute febrile stage of dengue infection can predict the disease outcome. PLoS One. 2009;4:e7892.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2775946</ArticleId><ArticleId IdType="pubmed">19936257</ArticleId></ArticleIdList></Reference><Reference><Citation>Ubol S, Masrinoul P, Chaijaruwanich J, Kalayanarooj S, Charoensirisuthikul T, Kasisith J. Differences in global gene expression in peripheral blood mononuclear cells indicate a significant role of the innate responses in progression of dengue fever but not dengue hemorrhagic fever. J Infect Dis. 2008;197:1459&#x2013;67.</Citation><ArticleIdList><ArticleId IdType="pubmed">18444802</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun P, Garc&#xed;a J, Comach G, Vahey MT, Wang Z, Forshey BM, et al. Sequential waves of gene expression in patients with clinically defined dengue illnesses reveal subtle disease phases and predict disease severity. PLoS Negl Trop Dis. 2013;7:e2298.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3708824</ArticleId><ArticleId IdType="pubmed">23875036</ArticleId></ArticleIdList></Reference><Reference><Citation>Lichtenstein AV, Melkonyan HS, Tomei LD, Umansky SR. Circulating nucleic acids and apoptosis. Ann N Y Acad Sci. 2001;945:239&#x2013;249. doi: 10.1111/j.1749-6632.2001.tb03892.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1749-6632.2001.tb03892.x</ArticleId><ArticleId IdType="pubmed">11708486</ArticleId></ArticleIdList></Reference><Reference><Citation>Ha TT, Huy NT, Murao LA, Lan NT, Thuy TT, Tuan HM, et al. Elevated levels of cell-free circulating DNA in patients with acute dengue virus infection. PLoS One. 2011;6:e25969. doi: 10.1371/journal.pone.0025969.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0025969</ArticleId><ArticleId IdType="pmc">PMC3189230</ArticleId><ArticleId IdType="pubmed">22016795</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>